Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.

Qaseem A, Snow V, Cross JT Jr, Forciea MA, Hopkins R Jr, Shekelle P, Adelman A, Mehr D, Schellhase K, Campos-Outcalt D, Santaguida P, Owens DK; American College of Physicians/American Academy of Family Physicians Panel on Dementia..

Ann Intern Med. 2008 Mar 4;148(5):370-8.

PMID:
18316755
2.

Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.

Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, Booker L, Oremus M.

Ann Intern Med. 2008 Mar 4;148(5):379-97. Review.

PMID:
18316756
3.

New drugs for Alzheimer's disease in Japan.

Takeda M, Tanaka T, Okochi M.

Psychiatry Clin Neurosci. 2011 Aug;65(5):399-404. doi: 10.1111/j.1440-1819.2011.02253.x. Review. No abstract available.

4.

Effective pharmacological management of Alzheimer's disease.

Atri A.

Am J Manag Care. 2011 Nov;17 Suppl 13:S346-55. Review.

5.

Drug therapy of dementia in elderly patients. A review.

Olsen CE, Poulsen HD, Lublin HK.

Nord J Psychiatry. 2005;59(2):71-7. Review.

PMID:
16195103
6.

Current and emerging pharmacological treatment options for dementia.

Ringman JM, Cummings JL.

Behav Neurol. 2006;17(1):5-16. Review.

PMID:
16720956
7.

Pharmacologic treatment options in Alzheimer's disease: optimizing disease management.

Aisen PS.

J Am Acad Nurse Pract. 2005 Mar;Suppl:5-7. Review.

PMID:
16033023
8.

[Current therapy of patients with dementia].

Fuchsberger T, Möller HJ, Hampel H.

MMW Fortschr Med. 2003 May 26;145 Suppl 2:49-52, 54. Review. German.

PMID:
14579485
9.

[Are anti-dementia drugs worthwhile?].

Lang CJ.

MMW Fortschr Med. 2007 Sep 13;149 Suppl 3:85-9. Review. German. Erratum in: MMW Fortschr Med. 2008 Jan 17;149 Suppl 4:136. dosage error in text.

PMID:
17955784
10.

Dementia.

Warner J, Butler R, Arya P.

Clin Evid. 2004 Dec;(12):1361-90. Review. No abstract available. Update in: Clin Evid. 2005 Dec;(14):1198-220.

PMID:
15865724
11.
12.

[Medical treatment of Alzheimer's disease].

Johannsen P.

Ugeskr Laeger. 2006 Oct 2;168(40):3424-9. Review. Danish.

PMID:
17032609
13.

[Mechanisms of action of Alzheimer medications].

Alhainen K.

Duodecim. 2003;119(20):1959-66. Review. Finnish. No abstract available.

PMID:
14640001
14.

Alzheimer disease and its management: a review.

Samanta MK, Wilson B, Santhi K, Kumar KP, Suresh B.

Am J Ther. 2006 Nov-Dec;13(6):516-26. Review.

PMID:
17122533
15.

Use of memantine for the treatment of dementia.

Lo D, Grossberg GT.

Expert Rev Neurother. 2011 Oct;11(10):1359-70. doi: 10.1586/ern.11.132. Review.

PMID:
21955192
16.

Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. A systematic review.

Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, Waugh N.

Int J Technol Assess Health Care. 2002 Summer;18(3):497-507. Review.

PMID:
12391943
17.

Treatment of Alzheimer's disease in the long-term-care setting.

Smith DA.

Am J Health Syst Pharm. 2009 May 15;66(10):899-907. doi: 10.2146/ajhp070622. Review.

PMID:
19420308
18.

Discontinuing Alzheimer's disease drug therapy: why, when, and how.

Crutchfield D.

Director. 2008 Winter;16(1):19-21. Review.

PMID:
19343870
19.

A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease.

Takeda A, Loveman E, Clegg A, Kirby J, Picot J, Payne E, Green C.

Int J Geriatr Psychiatry. 2006 Jan;21(1):17-28. Review.

PMID:
16323253
20.

Dementia.

Warner J, Butler R, Arya P.

Clin Evid. 2004 Jun;(11):1250-77. Review. No abstract available. Update in: Clin Evid. 2004 Dec;(12):1361-90.

PMID:
15652059

Supplemental Content

Support Center